Background. Analyses of the distribution and elimination of glucose 2.5% solutions can be used to suggest combinations of infusion rates and infusion times which yield a predetermined plasma glucose level and degree of plasma dilution during surgery.
The administration of glucose during surgery has been considered questionable as trauma-induced release of catecholamines, cortisol, and growth hormone impedes the glucose-lowering effect of insulin, which leads to hyperglycaemia. 4 The metabolic response is, however, reduced using laparoscopic techniques as compared with open surgery. 5 6 Many clinicians use glucose 2.5% with electrolytes during surgery, which is essentially a mixture of equivalent amounts of plain glucose 5% and acetated Ringer's solution. Little is known about how fast glucose 2.5% can be infused during laparoscopic surgery without causing blunt hyperglycaemia, which results in osmotic diuresis when the baseline concentration is almost tripled 7 and in a worse neurological outcome in case of cardiac arrest, which has been reported in laboratory animals having a 5-fold increase in plasma glucose. 8±10 Furthermore, the volume effect of the¯uid has not been studied during surgery, although rapid infusion of glucose 2.5% certainly affects the need for plasma volume expanders.
The aim of the present study was to describe the distribution and elimination of the glucose and volume components of glucose 2.5% during laparoscopic cholecystectomy. The glucose kinetics were analysed using traditional pharmacokinetic methods while the¯uid was studied using a volume kinetic model which considered the osmotic translocation of water associated with the uptake of glucose into the cells. 11 12 Nomograms were constructed to predict how fast glucose 2.5% needs to be infused to yield various predetermined glucose concentrations and dilutions of venous plasma. 13 14 
Materials and methods
The kinetics of an i.v. infusion of glucose 2.5% with electrolytes was studied during elective laparoscopic cholecystectomy in 12 patients aged between 27 and 51 yr (mean 40), two males and 10 females, and with a body weight of 58±88 (mean 75) kg. None were on any medication or had a family history of diabetes. The protocol was approved by the Local Ethics Committee and the informed consent of all patients was obtained.
The patients arrived at the hospital at 7 am and received no¯uid or food before the surgery started at 8.30 am. All of them were given 2.5±7.5 mg of ketobemidone by i.m. injection for pre-medication about 1 h before entering the operating theatre. A cannula was placed in the cubital vein of each arm for the respective purposes of sampling blood and infusing¯uid. The sampled plasma volume was replaced by the equivalent amount of saline 0.9%.
Without infusing any¯uid, general anaesthesia was induced with thiopental 5 mg kg ±1 and maintained with intermittent doses of 0.1 mg of fentanyl every 30 min and continuous administration of a gas mixture containing sevo¯urane 1±3% in oxygen and ambient air. Tracheal intubation was facilitated by i.v. injection of 0.5 mg kg ±1 of rocuronium. Monitoring of the patients included continuous pulse oximetry and electrocardiography.
When the ®rst skin incison was made, an i.v. infusion of iso-osmotic glucose 2.5% with electrolytes (Na + 70, Cl ± 45 and acetate 25 mmol litre ±1 ; Rehydrex, Pharmacia, Uppsala, Sweden) was started. As most patients receive about 1.5 litres of¯uid in connection with cholecystectomy at our hospital, we aimed at administering this volume to an 80-kg patient over 60 min, which was done via an infusion pump (Flo-Gard 6201, Baxter Healthcare Ltd, Deer®eld, IL, USA). After adjustment for body weight, the actual amount of¯uid was 1413 (SD 193) ml, which was infused at a rate of 23.6 (3.2) ml min ±1 . The dose of glucose was 35.3 (4.8) g or 196 (27) mmol. No more¯uid was given during the 240-min experiment.
Measurements
Venous blood was collected every 5 min during the ®rst 90 min and every 10 min for up to 240 min. The plasma glucose concentration was measured in single samples with the GLU Gluco-quant reagent (Roche Diagnostic Inc., Mannheim, Germany) on a Hitachi 917 (Hitachi Co., Naka, Japan). The blood haemoglobin (Hb) concentration, the red blood cell count (RBC) and the mean corpuscular volume (MCV) were measured in duplicate samples, and the baseline in triplicate samples, using Technicon Advia 120 (Bayer, Tarrytown, NY, USA). Venous blood was also withdrawn every 30 min for measurements of the serum sodium concentration by the Hitachi 917 system (Hitachi Co., Naka, Japan) and every 60 min for plasma insulin using an ELISA kit (Mercodia AB, Uppsala, Sweden). The coef®cient of variation for the 800 duplicate samples was 1.3% for Hb, 1.2% for RBC, and 0.2% for MCV, while serial testing yielded 5% for insulin.
The heart rate and arterial pressure were measured using an automatic device (Datex-Ohmeda Instrumentation Inc., Box 900, Finland) after each blood sampling procedure.
All patients had an indwelling urinary catheter, which was used to obtain data on the urine volume and the concentrations of glucose and sodium and potassium as measured by the Hitachi 917 system.
Glucose kinetics
The kinetics of glucose were calculated according to principles described in two previous laboratory studies, 11 12 but here the endogenous production of glucose (k i en ) was also estimated. The plasma concentration (C ex ) at any time (t) resulting from exogenous administration of glucose at the rate k i ex was calculated from the following equation:
in which V d is the volume of distribution and CL the clearance of glucose. The glucose concentration (C en ) resulting from endogenous production of glucose (k i en ) is given by:
The measured plasma glucose concentration is the sum of C ex and C en . Naturally, the endogenous production is After metabolism, thē uid equilibrates at a rate determined by k 31 . The elimination of¯uid is given by basal¯uid losses, k b , and a renal mechanism, k r . In this study, uid did not expand the dotted intermediate¯uid space.
responsible for the baseline concentration, and C en best re¯ects the production just before the infusion starts. Fitting these equations to the glucose data yielded the optimal estimates of V d , CL, and k i en . Elimination of glucose from V d represents active transport of glucose into the cells. The uptake of glucose to the cells was calculated individually for each time increment by using V d as the calibration factor between plasma glucose level and the amount of glucose in V d . The precise equations used are given elsewhere.
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Volume kinetics
The distribution and elimination of infused¯uid was studied by volume kinetic analysis. In the model used ( Fig. 1) , an i.v. infusion given at a constant rate (k i ) enters a body¯uid space having the volume (v 1 ) which strives to be maintained at the baseline volume V 1 by two elimination mechanisms; ®rst, elimination occurred at a controlled rate proportional by a constant k r to the expansion of V 1 and, secondly, at a ®xed rate at 0.5 ml min ±1 , which represents insensible¯uid losses. 14 An osmotic shift removes 3.6 ml water from V 1 per millimole of eliminated glucose. Both the glucose and the accompanying water then reside in the cells (V 3 ). Fluid later returns from the cells to V 1 after metabolism of the glucose, but the limited duration of the operations did not allow calculation of the constant k 31 which, when multiplied by the dilution of V 3 , yields this rate of redistribution. Therefore, the constant was set to 2.5´0.4´body weight, which is the average value obtained in three previous series of infusions of similar amounts of glucose 2.5%. 11 12 The equations used for these calculations appear in a previous publication.
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Calculations
The model parameters for the glucose and volume components of glucose 2.5% were calculated in each individual patient using Matlab version 6.5.1 (Math Works Inc., Natick, MA, USA). The kinetic models used a non-linear least-squares regression routine based on a modi®ed Gauss-Newton method. Input data obtained at baseline (time 0) and at any later time (t) comprised Hb, RBC and MCV and the baseline haematocrit. They were used to calculate the plasma dilution, which also represented the dilution of V 1 :
Corrections were made for iatrogenic dilution caused by the blood sampling, which averaged 7 ml for each sampling procedure. No correction for surgical bleeding was made; this amounted to 120 ml in one patient while no blood loss was recorded in the others. Weights inversely proportional to the predicted dilution plus 0.1 were applied. Output consisted in V 1 and k r along with the uncertainty of these estimates, expressed as their SD. Nomograms were constructed by simulating the expected plasma glucose and plasma dilution responses to various theoretical infusions of glucose 2.5% based on the numerical solutions to the differential equations describing the kinetic models. 13 14 The best estimate of the model parameters (Table 1) were inserted into the solutions which had been programmed into the Matlab software.
Intracellular accumulation of¯uid was calculated based on sodium and water balance. The equation for this`sodium dilution method' is given elsewhere.
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The results are expressed as the mean (SD). Because of skewed distributions, the median (interquartile range) was chosen where appropriate. Differences were evaluated by analysis of variance (ANOVA). Correlations between parameters were studied by simple and multiple linear regression. P<0.05 was considered signi®cant.
Results
Glucose kinetics
The plasma glucose concentration tripled during the infusion but returned to baseline during the 3-h follow-up ( Fig. 2A) . The variability of the concentration±time curves was quite small, and a simulation based on the average kinetic data from all infusions provided a good representation of them (Fig. 2B) .
The volume of distribution for glucose (V d ) averaged 9.14 litres, the clearance (CL) 0.21 litres min ±1 and the top) . In the entire group of 12 patients, the CL for glucose correlated with the endogenous glucose production (r=0.77; P<0.004; Fig. 3A ), but not to the baseline plasma glucose level, which was 5.1 (0.7) mmol litre ±1 . There was a 5-fold increase in the plasma insulin concentration during surgery (Fig. 3B ) and the concentration was also high at 120 min, although a marked decrease in the plasma glucose level had already occurred at that time.
Volume kinetics
The plasma dilution increased gradually during the infusion, too, and decreased to a quasi-steady state 30 min later (Fig. 4A) . The dilution±time curves showed more variability than the glucose concentration, although the kinetic analysis yielded an acceptable average curve during surgery (Fig. 4B) .
The analyses were stopped at the termination of anaesthesia, however, as awakening was often associated with marked haemoconcentration (Fig. 4C) and, in other cases, a transient but abrupt increase of the haemodilution (curves not shown). Therefore, the time period used for this curve®tting procedure was limited to 85 (67±106) min while the plasma glucose analysis was based on all data up to 240 min as waking up apparently did not affect this curve.
The size of the expanded central body¯uid space (V 1 ) averaged 3.89 litres and the elimination rate constant (k r ) was 36.7 ml min ±1 (Table 1 , bottom).
Haemodynamic variables and urine
The systolic and diastolic arterial pressures decreased during induction of anaesthesia (P<0.001) but increased when surgery and the glucose infusion started (P<0.01). Thereafter, the arterial pressures and the heart rate remained fairly constant until the end of anaesthesia 85 min later (Fig. 5) . The urinary excretion amounted to 48 (38±77) ml at 120 min, while being 127 (105±185) ml for the entire 240-min 12 Each point is one experiment. (B) The mean plasma insulin concentration in the 12 patients undergoing laparoscopic cholecystectomy. The error bars represent SD. study period. These volumes corresponded only to, respectively, 3.2 (2.7±6.0) and 9.1 (7.0±13.9)% of the infused volume.
The total urinary excretion of sodium was 12.1 (7.1±18.3) mmol, which is 12.8 (6.4±18.2)% of the administered amount of sodium. Minimal glycosuria occurred in most patients, amounting to 0.4 (0.1±6.4) mmol, which should be compared with the average amount of infused glucose of 196 mmol.
Serum sodium decreased from 139.3 (2.2) mmol litre ±1 at baseline to 136.1 (1.9) mmol litre ±1 at 90 min (P<0.001) but the concentration was then restored partly. The sodium dilution method indicated an intracellular accumulation of 433 (151) ml of¯uid at 120 min and 312 (222±353) ml at 240 min (P<0.001 vs baseline).
Simulations
The plasma glucose concentration expected to result from infusing glucose 2.5% at various rates is given in the form of a nomogram in Figure 6 . A corresponding nomogram for the expected plasma dilution is shown in Figure 7 .
Discussion
The current model for analysis and simulation of the distribution and elimination of glucose solution has been used in two previous volunteer studies. The ®rst one included the mathematical framework and compared the kinetics of glucose 2.5%, glucose 5%, and Ringer's solution. 11 The second study showed that both the exogenous glucose and the infused¯uid volume exhibit model linearity, that is, the kinetic analysis shows the same result for commonly used infusion rates and volumes. 12 An evaluation of the kinetics of glucose 2.5% during surgery is Table 1 . Please note the different scales for rate on the vertical axes.
Glucose 2.5% during laparoscopy a logical continuation of previous efforts. The results obtained during laparoscopic cholecystectomy show similarities to but also many differences from those obtained in the laboratory setting.
The volume of distribution (V d ) for the administered glucose molecules of 9.1 litres does not differ from that in the previous studies, but the clearance (CL) for glucose was only one-third of that obtained under laboratory conditions. 11 12 The difference in the rate of elimination may also be illustrated by comparing half-lives, which is given by V d * ln 2/CL. The half-life for glucose was 30 min during cholecystectomy while ranging between 11 and 16 min in the previous ®ve series of glucose infusions in volunteers. The slow elimination of glucose made the patients prone to develop hyperglycaemia. Plasma glucose reached a peak of 16 mmol litres ±1 , but this was followed by only minor glycosuria. Computer simulation indicates that the same infusion would increase plasma glucose to 10 mmol litre ±1 in a healthy volunteer. The low CL should prevent rebound hypoglycaemia, however, which is a potential problem when a brisk glucose infusion is stopped abruptly.
The low CL for glucose cannot be explained by insulin de®ciency as the plasma concentrations of this hormone were very similar to the levels measured in the volunteer studies in which CL was three times higher. 11 12 Therefore, insulin resistance was undoubtedly present 15 although laparoscopic cholecystectomy is only a moderately stressful operation. 5 Another study shows that glucose uptake was reduced by 20% the day after this operation 6 while the present results were obtained during the surgical procedure. Regardless of trauma, however, insulin resistance develops when fasting is long enough to markedly reduce glycogen stores. 16 The insulin resistance can be abolished by infusing large amounts of glucose before surgery 17 or glucose with insulin during surgery. 18 In the present study, a relative de®cit in the glucose supply is indicated by the endogenous glucose production, which was low (1.1 mmol min ±1 ) compared with that in volunteers subjected to similar glucose infusions in whom we calculated the same rate in retrospect (mean 2.6 mmol min ±1 ). 12 In both studies, the endogenous glucose production correlated closely with CL for glucose (Fig. 3A) . This implies that the endogenous glucose production increased with larger amounts of glucose being transported into the cells. This correlation could be expected as CL varied much more than the baseline glucose level. All subjects were in the fasting state, however, which makes anaesthesia and surgical trauma the most apparent factors that differed between the patients and the volunteers. The patients were 10 yr older than the volunteers and mostly women, but this difference is less likely to account for the difference in CL as the body weights were the same in the groups (75 and 77 kg).
The dilution±time curves showed a higher degree of intersubject variability than for plasma glucose. A prompt plasma dilution occurred in response to the ®rst fraction of the volume load, which might be explained by the vasodilatation resulting from the induction of anaesthesia, which allows more¯uid to ®ll the vascular system.
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Although no¯uid was infused, a plasma dilution of 5% was associated with the induction (data not shown), but this might not have fully accounted for the vasodilatation. Moreover, the surgical technique involves i.p. insuf¯ation of carbon dioxide, which could have affected the early plasma dilution response to glucose 2.5% by modifying the cardiovascular regulatory centres.
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The awakening from anaesthesia disturbed the dilution± time curve, which made it necessary for the kinetic analysis to involve the period of anaesthesia alone. As compared with laboratory conditions, the size of the body¯uid space expanded by the infused¯uid (V 1 ) was 10±20% larger while the elimination rate constant (k r ) was only between one-half and one-third as high. 11 12 This means that, in addition to the reduced distribution of¯uid to V 3 resulting from insulin resistance, the rate of elimination of¯uid from the kinetic system was also decreased in a way similar to the elimination of Ringer's solution during anaesthesia 18 and trauma surgery. 21 As k r corresponds to CL in conventional kinetics, the CL for glucose and¯uid appeared to be reduced to the same degree during laparoscopy.
The decrease in the rate of elimination of¯uid is even greater if we compare real data. Only 9% of the¯uid infused was excreted as urine after 4 h while the ®gure was 62% under non-surgical conditions. 12 Thus, the renal elimination of¯uid was in fact reduced twice as much by the surgery as indicated by the kinetic analysis. To examine how much uid is present in the kinetic system, one can multiply the size of V 1 by the dilution at any time and estimate the excess volume in V 3 in the same way. At 120 min, 175 ml of excess uid was present in V 1 and almost 500 ml in V 3 , the latter Fig 7 Nomogram showing the relationship between infusion rate and infusion time required to dilute the plasma to a predetermined degree (A) and the infusion rate required thereafter to maintain a steady-state dilution (B) during laparoscopic cholecystectomy in a patient weighing 75 kg. The steady-state rate is given for a 30-min infusion but should be increased by 3% for the shortest infusion rate (10 min) and reduced by 3% for the longest one (60 min). Please note the different scales for rate on the vertical axes.
®gure corresponding quite well to the intracellular accumulation of¯uid of 443 ml estimated by the sodium dilution method. With a urinary excretion of only 48 ml at this time, the amount of`missing'¯uid is as large as 700 ml. This discrepancy has not been encountered in our volunteer experiments. 11 12 Excessive evaporation from the airways during general anaesthesia might account for part of this volume, but there are two other possible explanations for the`missing'¯uid. The ®rst is that the glucose solution occupied the¯uid space between V 1 and V 3 , which has been considered but not supported by the mathematical analysis. Computer simulations show that this space (V 2 ) is likely to be expanded when CL and k r are very low. In this study, the shape of the dilution±time curve typical for the presence of an intermediate body¯uid space expanded by¯uid was not present, but the relatively high variability of the curves and the fact that the curve-®tting was based on data from only 2 h make it impossible to rule out such a possibility. The second explanation relates to the ®nding that iso¯urane anaesthesia creates a similar discrepancy between model-predicted elimination and renal excretion when saline 0.9% is infused in sheep. 22 The effect is not a result of the mechanical ventilation but to the iso¯urane itself. 23 In the present study, anaesthesia was maintained with sevo¯urane, which might cause the same`third-spacing' effect as iso¯urane. Where the¯uid resides is not known but, in any event, it does not readily equilibrate with V 1 .
The results of the kinetic analyses were illustrated by nomograms, which may be useful in clinical practice. They show that infusing glucose 2.5% at a constant rate throughout laparoscopic cholecystectomy is not optimal therapy. To prevent hyperglycaemia and progressive volume expansion, the infusion rate should be high at the beginning of surgery and then slowed down. In the nomogram for glucose, the anaesthetist can choose an acceptable increase in plasma glucose during and immediately after laparoscopy (Fig. 6) . After having selected an acceptable`target' rise in plasma glucose in the left part of the nomogram, any combination of infusion rates or infusion times can be used to hit the isobar showing the accepted increase. Once this`target' is reached, the task is then to infuse enough glucose 2.5% to maintain the plasma concentration. This is done by following the isobar to the right and turning down the infusion rate to the value obtained in that part of the ®gure.
The nomogram for plasma dilution is based on the same principle as the one for plasma glucose, the only difference being that the steady-state level varied slightly, about 6% between a 10-and a 60-min infusion, because of variable amounts of¯uid returning from V 3 after metabolism of the glucose. The volume effect of glucose 2.5% is not negligible and should be considered when administering the¯uid (Fig. 7) . For example, an increase of plasma glucose by 2 mmol litre ±1 to slightly above the normal range can apparently be maintained by supplying glucose 2.5% at a rate of 3 ml min ±1 (180 ml h ±1 ). The infused¯uid volume then dilutes the plasma by 7%, which corresponds to a plasma volume increase of about 250 ml in a normal-sized patient.
In conclusion, kinetic analysis of glucose 2.5% solution during laparoscopic cholecystectomy showed low values for endogenous glucose production and for the clearance of glucose and infused¯uid volume. This results in an altered disposition of the¯uid. 
